Shawnte Mitchell
Chief Legal Officer at Olema Pharmaceuticals, Inc. (OLMA) since February 2025
Shawnte Mitchell has filed 8 insider reports with the SEC since March 2021, as chief Legal Officer at Olema Pharmaceuticals, Inc. (OLMA) and officer at Zogenix, Inc. (ZGNX). In the last 12 months Shawnte Mitchell sold $952K of stock on the open market. In the latest filing, on March 6, 2026, Shawnte Mitchell sold 40,000 shares of Olema Pharmaceuticals, Inc. (OLMA) for $952K at an average of $23.79.
- Filings
- 8
- Companies
- 2
- Bought on market
- None
- Sold on market
- $952K
Companies where Shawnte Mitchell is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Legal Officersince February 2025 | 233 | $952K | $7.02 | Mar 6, 2026 | |||
| Officer | 0 | Mar 10, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 4, 2026-$952KOLMACHIEF LEGAL OFFICER Mitchell Shawnte exercised 40,000 shares at a strike of $4.37, sold $945,750 worth of shares (39,767 units at $23.78) and sold $5,753 worth of Comon Stock (233 units at $24.69)Form 4Exercise or conversion of a derivativeOpen-market sale
- Mar 4, 2026~$599KOLMAShawnte Mitchell plans to sell 25,000 shares (~$599K)Form 144Planned sale
- Mar 3, 2026~$345KOLMAShawnte Mitchell plans to sell 15,000 shares (~$345K)Form 144Planned sale
- Feb 2, 2026OLMASEC Form 4 filed by CHIEF LEGAL OFFICER Mitchell ShawnteForm 4Grant or award
- Feb 28, 2025OLMASEC Form 4 filed by CHIEF LEGAL OFFICER Mitchell ShawnteForm 4Grant or award
- Feb 18, 2025OLMAShawnte Mitchell became an insiderForm 3New insider
- Mar 7, 2022ZGNXSEC Form 4: Mitchell Shawnte closing all direct ownership in the company (tax withholding)Form 4Sale back to the companyTender of shares in a change of control
- Mar 26, 2021ZGNXSEC Form 4 filed by Shawnte MitchellForm 4Grant or award
Compare Shawnte Mitchell with
- Shawnte Mitchell vs Jason O'Byrne1 shared
- Shawnte Mitchell vs Cyrus Harmon1 shared
- Shawnte Mitchell vs Cynthia M Butitta1 shared
- Shawnte Mitchell vs J. Scott Garland1 shared
- Shawnte Mitchell vs Gorjan Hrustanovic1 shared
- Shawnte Mitchell vs Ian T Clark1 shared
Other insiders at the same companies
- Jason O'ByrneOLMA
- Cyrus HarmonOLMA
- Bvf Partners L P/ilOLMA
- Cynthia M ButittaOLMA
- J. Scott GarlandOLMA
- Gorjan HrustanovicOLMA
- Ian T ClarkOLMA
- Yi LarsonOLMA
- Sandra HorningOLMA
- Prakash RamanOLMA
- Andrew RappaportOLMA
- G. Walmsley GrahamOLMA
- Kovacs Shane William CharlesOLMA
- Sasha Lu AustinOLMA
- David C. MylesOLMA
- Naseem ZojwallaOLMA
Questions about Shawnte Mitchell
- What is Shawnte Mitchell's role at Olema Pharmaceuticals, Inc.?
- Shawnte Mitchell reports to the SEC as chief Legal Officer at Olema Pharmaceuticals, Inc. (OLMA), according to the latest filing on March 6, 2026. Shawnte Mitchell has also filed as officer at Zogenix, Inc. (ZGNX).
- How many shares does Shawnte Mitchell own?
- After the latest filing that states it, Shawnte Mitchell directly owned 233 shares of Olema Pharmaceuticals, Inc. (OLMA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Shawnte Mitchell bought or sold stock recently?
- The most recent open-market sale was on March 4, 2026: sold 40,000 shares of Olema Pharmaceuticals, Inc. (OLMA) for $952K at an average of $23.79.
- How do I get alerts when Shawnte Mitchell files?
- Follow Shawnte Mitchell on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Shawnte Mitchell (SEC CIK 0001749432). Totals count each trade once, skipping amendments whose original is on file, from Mar 31, 2021 on. View on SEC EDGAR · Get this as JSON